Asia-Pacific Oncology Molecular Diagnostics Market Analysis Future Trends and Growth Opportunity

Sanyukta K

Asia-Pacific Oncology Molecular Diagnostics Market Analysis Future Trends and Growth Opportunity

Molecular diagnosis is a method used to identify a disease at the molecular level, such as proteins, DNA, and RNA, in a tissue or fluid. Various tools are used to detect specific sequences of DNA or RNA that may or may not be associated with the disease such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions, which are used for diagnosis and prediction of various infectious diseases, cancer, and other genetic disorders.

Request for Sample Report: https://www.alliedmarketresearch.com/request-sample/6652

According to Allied Market Research, the “Asia-Pacific oncology molecular diagnostics market was valued at $381.84 million in 2018 and is estimated to reach $732 million by 2026 growing at a CAGR of 9% for the forecast period of 2019–2026”. Factors such as increase in prevalence of various types of cancer, rise in awareness and acceptance of personalized medicines, and growth in biomarker identification drive the growth of this oncology molecular diagnostics market.

The market is segmented on the basis of application, end user, and country. By application, it is segmented into colorectal, lung, hematological, breast, and others.. By end-user, it is categorized into hospitals, reference laboratories, and others (research institutes and academic institutes).

Country wise, the Asia-Pacific oncology molecular diagnostics market is analyzed across Australia, Vietnam, the Philippines, Thailand, and rest of Asia-Pacific. Australia was the highest contributor with $91.26 million in 2018, and is estimated to reach $175.55 million by 2026, registering a CAGR of 9.0% during the forecast period. This is attributed to rise in incidences of cancer cases and surge in demand for faster diagnosis of cancer.

Key Market Players

· ABBOTT LABORATORIES

· bioMérieux SA

· Qiagen N.V.

· F. Hoffmann-La Roche Ltd

· Siemens Healthineers

· Danaher (Cepheid)

· Diasorin SPA

· Illumina Inc.

· Agilent Technologies Inc.

· Sysmex Corporation

Key Advantages of the Report

· This report provides a detailed quantitative analysis of the current Asia-Pacific oncology molecular diagnostics market trends and forecast estimations

· An in-depth oncology molecular diagnostics market analysis includes analysis of various regions

· A comprehensive analysis of factors that drive and restrain the growth of the global is provided.

· Country-wise market conditions are comprehensively analyzed in this report.

· Key market players within the oncology molecular diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook.

Sanyukta K

Oncology Molecular Diagnostics Market 2022| Industry Trends, Outlook, And Demand

Biswadeep 2022-03-21

With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected oncology molecular diagnostics market growth numbers from 2022-2031. id=3457&type=smp The global oncology molecular diagnostics market size is expected to grow from $3. Impact Of COVID-19 On The Oncology Molecular Diagnostics Market5. Key Mergers And Acquisitions Of The Oncology Molecular Diagnostics Market29. Future Outlook and Potential Analysis Of The Oncology Molecular Diagnostics Market About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Global Oncology Molecular Diagnostics Market 2024 - By Size, Drivers, Trends, Competitors And Overview By 2033

sai tbrc 2024-03-14

Learn More On The Oncology Molecular Diagnostics Market:https://www. The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the oncology molecular diagnostics market over the coming years. Abbott LaboratoriesDanaher CorporationThe advanced technology in genomics is a key trend in the oncology molecular diagnostics market. The oncology molecular diagnostics market report table of contents includes:1.

Molecular Oncology Diagnostics Market is Expected to Reach $12,130.5 million by 2032

bisresearch reports 2022-11-29

The growth in the global molecular oncology diagnostics market is expected to be driven by the rising prevalence of cancers and increased transformations in biomarker identification. Some of the prominent names in this market are:• Agilent Technologies, Inc. Additionally, emerging technologies like microarray are also expected to be integrated more into molecular oncology diagnostics soon, which is expected to further boost market growth. Growth/Marketing Strategy: The key components in molecular oncology diagnostics are the kit and assay, instrument, and software. Competitive Strategy: The key players in the global molecular oncology diagnostics market analyzed and profiled in the study consist of product-based companies.

Oncology Molecular Diagnostics Market Demand Analysis, Statistics, Industry Trends And Investment Opportunities To 2028

Faisal Gocher 2022-04-08

The new research report titled "Oncology Molecular Diagnostics Market, Global Industry Analysis, and Forecast to 2028" gives a detailed analysis and future forecasts of the market. The major players in the oncology molecular diagnostics market include Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche Diagnostics, Others. Get more information on "Global Oncology Molecular Diagnostics Market Research Report" by requesting FREE Sample Copy at https://www. The emergence of practical applications of molecular oncology is largely attributed to the development of user-friendly methods of molecular analysis. By Type· Breast Cancer· Prostate Cancer· Colorectal Cancer· Cervical Cancer· Liver Cancer· Lung Cancer· Blood Cancer· Kidney Cancer· OtherBy Product· Instruments· ReagentsBy Technology· PCR· Multiplex PCR· In Situ Hybridization· Isothermal Nucleic Acid Amplification Technology (INAAT)· Chips & Microarrays· Mass Spectrometry· Sequencing· Transcription Mediated AmplificationRegional AnalysisThis section covers regional segmentation which accentuates on current and future demand for oncology molecular diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Molecular Oncology Diagnostics Market to increase at an annual CAGR of 11.43% over the Forecast period 2022-2032 | BIS Research

Tanzeel Obaid 2023-02-21

Segmentation 2: by Technology• Next-Generation Sequencing (NGS)• Polymerase Chain Reaction (PCR)• Immunohistochemistry (IHC)• Fluorescence In-Situ Hybridization (FISH)• Flow Cytometry• Other TechnologiesBased on technology, the global molecular oncology diagnostics market is dominated by polymerase chain reaction (PCR). Segmentation 4: by Cancer Type• Solid Tumor o Breast Cancer o Lung Cancer o Colorectal Cancer o Prostate Cancer o Ovarian Cancer o Other Solid Tumors• Hematological Malignancy o Lymphoma o Leukemia o Multiple Myeloma o Other Hematological MalignanciesBased on cancer type, the global molecular oncology diagnostics market is dominated by solid tumor cancer type, where breast cancer is expected to be the leading segment. Segmentation 5: by End User• Hospitals and Diagnostic Centers• Reference Laboratories• Pharmaceutical and Biotechnology Companies• Academic and Research InstitutesBased on end users, global molecular oncology diagnostics was dominated by the hospitals and diagnostic centers segment. Segmentation 6: by Region• North America• Europe• Asia-Pacific• Rest-of-the-WorldNorth America dominated the global market with a revenue of $1,588. Competitive Strategy: The key players in the global molecular oncology diagnostics market analyzed and profiled in the study consist of product-based companies.

Molecular Diagnostics Market Revenue, Trends, Market Share Analysis, and Forecast to 2032

David 2023-09-20

Based on technology, the molecular diagnostics industry from the sequencing segment is anticipated to garner significant gains through 2032, owing to higher diagnostic sensitivity and cost-effectiveness of next-generation sequencing (NGS). From the regional perspective, Europe molecular diagnostics industry is expected to record a valuation of over USD 8. 3 Technology trends2. , is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Toll Free: 1-888-689-0688USA: +1-302-846-7766Europe: +44-742-759-8484APAC: +65-3129-7718Email:sales@gminsights.

WHO TO FOLLOW